ストックスクリーナーアプリを入手
27.43
1.25%
-0.346
前日終値:
$27.77
開ける：
$27.82
24時間の取引高:
8,925
Relative Volume:
0.52
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.16%
1か月 パフォーマンス:
+7.26%
6か月 パフォーマンス:
+9.01%
1年 パフォーマンス:
-4.80%
1日の値動き範囲:
$27.37
$27.82
1週間の範囲:
$26.93
$27.82
52週間の値動き範囲:
$20.10
$29.81
Tema Oncology Etf Stock (CANC) Company Profile
CANC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
27.43 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
324.31 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
657.41 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
660.72 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.41 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
586.66 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf (CANC) 最新ニュース
Tema Etfs LLC Increases Stake in Nurix Therapeutics, Inc. $NRIX - MarketBeat
How to Take Advantage of moves in (CANC) - news.stocktradersdaily.com
Analysts Predict Tema Oncology ETF to Reach $40, with Stocks CELC, ACLX, and ZYME Showing Significant Upside Potential - AInvest
Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest
Summit Therapeutics Soars 16.5% Amid Regulatory Crossroads and Whale Activity - AInvest
When (CANC) Moves Investors should Listen - news.stocktradersdaily.com
5 Small-cap Biotech ETFs to Watch - Investing News Network
(CANC) Investment Report - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Learn to Evaluate (CANC) using the Charts - news.stocktradersdaily.com
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
(CANC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
(CANC) Investment Analysis and Advice - news.stocktradersdaily.com
Trend Tracker for (CANC) - Stock Traders Daily
How To Trade (CANC) - Stock Traders Daily
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - CMC Markets
Pursuing A Better Way To Invest In Life Sciences | Opto Partners - CMC Markets
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
9 Best Biotech ETFs for 2024 - AOL.com
11 Best Biotech ETFs To Buy - Yahoo Finance
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema Launches Third Medical-Themed ETF - FA Mag
New ETF Focuses On Obesity, Cardiovascular Disease Treatments - FA Mag
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
NYSE Active ETF Update | October 12, 2023 - NYSE
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Inside Tema ETFs' New Oncology ETF (CANC) - Yahoo Finance
Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews
This Week in ETFs: 2 New Funds Launch From Tema - Yahoo Finance
Thematic ETFs Struggle to Capture Financial Advisors’ Attention - ETF.com
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
The 5 Best Biotech ETFs of 2024 - ETF.com
Getting in on global luxury - ETF Strategy
Tema Oncology Etf (CANC) 財務データ
Tema Oncology Etf (CANC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.61%
0.34%
大文字化:
|
ボリューム (24 時間):